ArticleBMC health services research2012

A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting.

Sonja Zindel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.